Next Article in Journal
Hyperglycemia in Pregnancy-Associated Oxidative Stress Augments Altered Placental Glucose Transporter 1 Trafficking via AMPKα/p38MAPK Signaling Cascade
Next Article in Special Issue
KARAJ: An Efficient Adaptive Multi-Processor Tool to Streamline Genomic and Transcriptomic Sequence Data Acquisition
Previous Article in Journal
Biofabrication of Sodium Alginate Hydrogel Scaffolds for Heart Valve Tissue Engineering
 
 
Article
Peer-Review Record

Predicting the Prognostic Value of POLI Expression in Different Cancers via a Machine Learning Approach

Int. J. Mol. Sci. 2022, 23(15), 8571; https://doi.org/10.3390/ijms23158571
by Xuan Xu 1,2,3, Majid Jaberi-Douraki 2,3,* and Nicholas A. Wallace 1,*
Reviewer 1:
Reviewer 2:
Int. J. Mol. Sci. 2022, 23(15), 8571; https://doi.org/10.3390/ijms23158571
Submission received: 21 June 2022 / Revised: 22 July 2022 / Accepted: 25 July 2022 / Published: 2 August 2022
(This article belongs to the Special Issue Bioinformatics in Genetic Diseases and Cancer)

Round 1

Reviewer 1 Report

This manuscript indicated novel prediction model of cancer survival using POLI expression by machine learning. This study is very important as new prognostic tool for different cancers. But, some corrections may be required. As correlation coefficient of POLI,  Pearson correlation coefficient is used in Table 1. In addition, it is better to add other correlation coefficients such as spearman's rank correlation coefficient and  Kendall rank correlation coefficient as non-parametric method. In addition, it was better to add other classifier algorithms than random forest, such as XGboost, LightGBM, neural networks, etc., and to compare these results. Also, it is better to add the advantages and disadvantages of this new strategy in discission section.

Line 287, page 10, typo:Forrest  

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

Comment 1.

In order for the authors to substantiate their scientific conclusion in the manuscript, the authors should check the following things in their datasets for the cancer patients.

First, how many of the cancer patients have mutations in the POLI gene ?

Second, is there a statistically significant difference in POLI mutation status between one group(POLI high expression showing worsening survival) and other group(POLI high expression showing improved survival) ? If so, their scientific conclusion in the manuscript should not be based on present mechanistic explanation, but otherwise mechanistic explanation.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Back to TopTop